Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENS: Sequential vs Upfront Neoadjuvant Chemotherapy in Breast Cancer
NCT00314977Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2006
- Primary completion
- Apr 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, cyclophosphamide, docetaxel in breast cancer, sponsored by Radboud University Medical Center. Started Feb 2006; status: completed.
02
Drugs
doxorubicincyclophosphamidedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00314977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314977.